PRIMAQUINE PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Primaquine Phosphate, and when can generic versions of Primaquine Phosphate launch?
Primaquine Phosphate is a drug marketed by Alvogen, Bayshore Pharms Llc, and Novast Labs. and is included in three NDAs.
The generic ingredient in PRIMAQUINE PHOSPHATE is primaquine phosphate. There are four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the primaquine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Primaquine Phosphate
A generic version of PRIMAQUINE PHOSPHATE was approved as primaquine phosphate by BAYSHORE PHARMS LLC on February 25th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRIMAQUINE PHOSPHATE?
- What are the global sales for PRIMAQUINE PHOSPHATE?
- What is Average Wholesale Price for PRIMAQUINE PHOSPHATE?
Summary for PRIMAQUINE PHOSPHATE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 85 |
| Clinical Trials: | 40 |
| Patent Applications: | 832 |
| What excipients (inactive ingredients) are in PRIMAQUINE PHOSPHATE? | PRIMAQUINE PHOSPHATE excipients list |
| DailyMed Link: | PRIMAQUINE PHOSPHATE at DailyMed |
Recent Clinical Trials for PRIMAQUINE PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, San Francisco | Phase 2/Phase 3 |
| Pan American Health Organization | Phase 2/Phase 3 |
| Mahidol Oxford Tropical Medicine Research Unit | Phase 4 |
Pharmacology for PRIMAQUINE PHOSPHATE
| Drug Class | Antimalarial |
Medical Subject Heading (MeSH) Categories for PRIMAQUINE PHOSPHATE
Anatomical Therapeutic Chemical (ATC) Classes for PRIMAQUINE PHOSPHATE
US Patents and Regulatory Information for PRIMAQUINE PHOSPHATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alvogen | PRIMAQUINE PHOSPHATE | primaquine phosphate | TABLET;ORAL | 203924-001 | Feb 3, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bayshore Pharms Llc | PRIMAQUINE PHOSPHATE | primaquine phosphate | TABLET;ORAL | 204476-001 | Feb 25, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Novast Labs | PRIMAQUINE PHOSPHATE | primaquine phosphate | TABLET;ORAL | 206043-001 | Jun 23, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
